Because none of the observed sequence variations correlated with the well known mutations known to confer Oseltamivir resistance and none of the variations were in the active site [10], it was suggested that the decrease in sensitivity might be due to drift mutations rather than from exposure to Oseltamivir.
In SIFT (http://sift.bii.a-star.edu.sg/) the M158V mutation, as well as the known mutation R155H, was not tolerated (p = 0.00), meaning that the mutation is deleterious.
Here, we investigated whether epigenetic silencing of Wnt antagonists is the biological driver for this increased Wnt activity in human tissues and how these methylation changes correlate with MSI (Microsatelite Instability) and CIMP (CpG Island Methylator Phenotype) statuses as well as known mutations in genes driving colorectal neoplasia.
While it is well known that mutation of components of the Set2-Rpd3S produce producryptictranscriptsipts, co-activators that affect transcription from cryptic promoters have not been well characterized.
Surprisingly, the well known activating mutation of the transmembrane span (V659E, Neu), which alters one of the GXXXG motifs, destabilizes interactions and has been suggested to shift the equilibrium of two alternative packing modes representing the active and inactive state of the receptor [ 43].
Although it is well known that mutation in APC, CTNNB1 and AXIN is infrequent in GC, we found that the majority of GC cells showed activation and nuclear accumulation of β-catenin and methylation of multiple SFRP genes (Nojima et al, 2007).
On the other hand it is well known that mutations in the apoptotic program (i.e. p53 mutations) and up-regulated pro-survival signals (anti-apoptotic Bcl2 family members) in established cancers contribute to resistance to apoptotic cell death and are important aspects of resistance to anticancer therapies [ 42, 43].
These data compliment previous reports of an expanding spectrum of phenotypes of this known mutation, as well as associating the DCM phenotype with gain-of-function sodium channel mutations for the first time.
The loss-of-signal mechanism has the advantage that it is more parsimonious since it only affects the signaling capacity, which fits well with the allele's known mutation in the kinase domain.
In further support of this notion, it is well known that mutations of CDC25, a RasGrf1 homolog in yeast [ 8] or mutations of the Ras pathways in C. elegans [ 9] also lead to extended life span.
BRCA1 and BRCA2 are the most well known gene mutations responsible for an increased risk for developing breast cancer.
